What’s Behind the Price Tag of Medication

We are in the midst of an accessibility and affordability crisis in healthcare. Costs are sky high, the price of new therapies coming to market is alarming, all the while, care is not getting any better and gaping holes in access still persist in many vulnerable populations. Breakthrough therapies? benefits are diminished when the price tag attached makes them unattainable to most who are in need. So if affordability means someone ultimately gets paid less, who is willing to take a pay cut? The drug supply chain historically has been passing cost along to the patient, instead of savings. How can we realign incentives, identify who is getting paid for things that should not be and truly trim some fat out of the system. Join pharmacy leaders to candidly discuss the road to achieve drug price transparency and affordability.